Rare diseases
Investigational molecules
Locations
Back to Germany1 675 clinical trials in Essen, Germany across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Emavusertib for Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome
GermanyStudy of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
GermanyStudy Comparing BI 907828 and Doxorubicin for Patients with Advanced Dedifferentiated Liposarcoma
GermanyStudy of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy
GermanyStudy of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older
GermanyStudy on the Effects of Efgartigimod Alfa for Patients with Generalized Myasthenia Gravis
GermanyStudy on the Effects of TAK-341 for Patients with Multiple System Atrophy
GermanyStudy of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation
GermanyStudy on CK-0045 for Patients with Type 2 Diabetes and Obesity
GermanyStudy of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)
GermanyStudy on Chemotherapy-Free Treatment with Trastuzumab, Pertuzumab, and T-DM1 for Patients with HER2-Positive Early-Stage Breast Cancer
GermanyStudy on the Safety and Effectiveness of CRISPR-Cas9 Modified Stem Cells for Patients with Transfusion-Dependent Beta-Thalassemia Using Exagamglogene Autotemcel
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on metastatic colorectal cancer, breast cancer, and lymphoma treatments. Studies evaluate novel therapeutic combinations and targeted approaches for various cancer types.
Research includes evaluation of new drug combinations and immunotherapy approaches.
Studies examining preventive treatments for respiratory syncytial virus and related infections. Research focuses on vaccine development and immune response in different age groups.
Emphasis on protecting vulnerable populations including older adults and at-risk individuals.
Clinical research addressing Alzheimer's disease and acute cerebral ischemic stroke. Investigations into novel therapeutic approaches and diagnostic tools.
Focus on improving patient outcomes through innovative treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
